Skip to content
Clinical Trials – home

Slagelse Hospital

Research site

Denmark Ingemannsvej 18, 4200 Slagelse, Denmark

  • 11 trials recruiting
  • Cardiovascular disorder · Peritonitis · Arteriosclerosis
  • Adults and children

About Specializations

Slagelse Hospital in Slagelse, Denmark specialises in clinical trials of conditions such as Cardiovascular disorder, Peritonitis, Arteriosclerosis, Cardiac failure, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Research

At Slagelse Hospital, a major share of the clinical trial portfolio focuses on cardiovascular diseases, including heart failure, atrial fibrillation, myocardial infarction, and broader atherosclerotic cardiovascular disease. These studies are designed to test new treatments, lower the risk of serious heart and vascular events, and improve long-term outcomes for people with high cardiovascular risk.

  • Testing therapies to prevent stroke, heart attack, and other major cardiovascular events
  • Evaluating treatments for chronic and acute heart failure
  • Studying risk reduction in patients with established or high-risk cardiovascular disease

Research in this area also includes strategies for managing hypertension and improving care for patients with elevated lipoprotein(a) or other cardiovascular risk factors.

Emergency and Critical Care

The site conducts important trials in acute care, intensive care, and anesthesia and analgesia, with a strong focus on urgent conditions such as sepsis, septic shock, and in-hospital cardiac arrest. The aim is to improve survival, support recovery, and identify better treatment approaches for critically ill patients.

  • Assessing treatments for sepsis and severe infection in critically ill adults
  • Evaluating emergency interventions during cardiac arrest and acute heart failure
  • Comparing care strategies used in intensive care and hospital emergency settings

These studies reflect a practical focus on improving outcomes in time-sensitive situations where treatment decisions must be made quickly.

Digestive System and Surgical Care

Clinical research at Department of Surgery in Slagelse Hospital also covers digestive system diseases and perioperative care, including major emergency abdominal surgery and peritonitis. The trials are aimed at improving infection control, nutritional support, and recovery after surgery.

  • Studying ways to reduce infections after emergency abdominal surgery
  • Testing treatments for complex abdominal infections such as peritonitis
  • Exploring supportive care approaches that may improve postoperative recovery

This area of research is especially relevant for patients facing urgent surgical treatment and complicated abdominal illness.

Oncology and Cancer Supportive Care

The site is involved in neoplasm research, especially colorectal cancer and localized colon cancer. These trials look at ways to strengthen cancer treatment, improve immune response, and support physical recovery during and after therapy.

  • Evaluating new approaches to improve treatment response in colorectal cancer
  • Studying supportive therapies that may help physical capacity and recovery
  • Investigating immune-related changes linked to cancer care

Research in this area combines cancer treatment with broader supportive care goals, including better quality of life and improved patient resilience.

Neurology, Musculoskeletal, and Metabolic Conditions

Several trials at the site address nervous system diseases, musculoskeletal diseases, and nutritional and metabolic diseases, including multiple sclerosis, psoriatic arthritis, axial spondyloarthritis, fracture care, and type 1 diabetes. The research is focused on testing better disease control, easing symptoms, and supporting function in everyday life.

  • Studying therapies for relapsing multiple sclerosis
  • Assessing treatment effects in inflammatory joint and spine disease
  • Exploring ways to preserve beta cell function in early type 1 diabetes

These studies show a broad interest in chronic inflammatory and metabolic conditions, alongside practical care for acute injuries.

Quality of Care and Diagnostic Support

Some of the research at Slagelse Hospital also addresses health care quality and clinical decision-making, with a focus on improving treatment choices and patient outcomes across different specialties. This includes studies that compare established care options and evaluate how well they work in real-world hospital settings.

  • Comparing standard treatments to identify the most effective care strategies
  • Supporting better clinical decisions in urgent and chronic disease management
  • Improving the overall quality and effectiveness of hospital-based care

Across its trial portfolio, the site contributes to research that is both clinically practical and directly relevant to patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ingemannsvej 184200 SlagelseDenmark
Recruiting now
11 trials
Conditions studied
32

More sites in SlagelseDenmark

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

31 clinical trials

Study of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Zilebesiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Colitis ulcerative+1

Recruiting

A study of mirikizumab levels in breast milk of breastfeeding women with ulcerative colitis or Crohn's disease

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Intensive care

Recruiting

Evaluation of enoxaparin, dalteparin, nadroparin, tinzaparin and human albumin in adults admitted to intensive care unit with acute critical illness

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dalteparin Sodium
  • Sponsor:Region Hovedstaden

Iron deficiency

Recruiting

Study on the Effects of Intravenous Ferric Derisomaltose in Non-Anemic Iron Deficient Patients with Colorectal Cancer

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ferric Derisomaltose
  • Sponsor:Region Sjaelland

Sepsis+1

Recruiting

Study Comparing Meropenem and Piperacillin/Tazobactam for Adults with Sepsis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Linezolid
  • Sponsor:Region Hovedstaden

Comparison of Furosemide, Nitrates, or Their Combination for Initial Treatment of Pulmonary Congestion in Patients with Acute Heart Failure

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Region Hovedstaden

Study on the Effect of Influenza Vaccine on Preserving Beta Cell Function in Early Type 1 Diabetes Patients

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Sponsor:Region Midtjylland

Rheumatoid arthritis

Not yet recruiting

Effect of High‑Dose Thiamine Hydrochloride on Fatigue in Rheumatoid Arthritis Patients: Randomized, Double‑Blind, Placebo‑Controlled Trial

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Thiamine Hydrochloride
  • Sponsor:Odense University Hospital
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.